Amgen (AMGN) Accumulated Expenses (2009 - 2026)
Amgen (AMGN) recorded Accumulated Expenses of $17.19 billion in Q2 2026, up 14.4% from $15.02 billion a year earlier and up 3.7% from the prior quarter.
Powered by 
Analysis
Amgen (AMGN) Accumulated Expenses (2009 - 2026) Analysis & Trends
At the end of FY2025, Amgen reported Accumulated Expenses of $18.52 billion, up 5.0% from FY2024.
- Annual Accumulated Expenses has increased for ten straight years, with a five-year compound annual growth rate of 12.8% (FY2020 to FY2025).
- Across earlier years, Accumulated Expenses came in at $17.64 billion in FY2024 (+14.9%), $15.36 billion in FY2023 (+22.6%), $12.52 billion in FY2022 (+16.7%) and $10.73 billion in FY2021 (+5.8%).
- Quarterly Accumulated Expenses has ranged from $9.38 billion in Q3 2021 to $18.52 billion in Q4 2025 over the past five years.
- On a year-over-year basis, Accumulated Expenses rose in seven of the last eight quarters, with growth averaging 10.0%.
- Peak year-over-year performance for Accumulated Expenses in the last five years was growth of 30.1% in Q2 2023, against a decline of 3.8% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $16.58 billion (Q1 2026), $18.52 billion (Q4 2025) and $16.8 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn |
| 10 | Vertex Pharmaceuticals | 133.09 Bn | 105.09 Bn | 2.84 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.19 Bn |
| Mar 31, 2026 | 16.58 Bn |
| Dec 31, 2025 | 18.52 Bn |
| Sep 30, 2025 | 16.80 Bn |
| Jun 30, 2025 | 15.02 Bn |
| Mar 31, 2025 | 17.23 Bn |
| Dec 31, 2024 | 17.64 Bn |
| Sep 30, 2024 | 14.62 Bn |
| Jun 30, 2024 | 13.72 Bn |
| Mar 31, 2024 | 14.13 Bn |
| Dec 31, 2023 | 15.36 Bn |
| Sep 30, 2023 | 14.17 Bn |
| Jun 30, 2023 | 13.72 Bn |
| Mar 31, 2023 | 12.06 Bn |
| Dec 31, 2022 | 12.52 Bn |
| Sep 30, 2022 | 11.58 Bn |
| Jun 30, 2022 | 10.55 Bn |
| Mar 31, 2022 | 10.64 Bn |
| Dec 31, 2021 | 10.73 Bn |
| Sep 30, 2021 | 9.38 Bn |
API Access
Amgen Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=AMGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "AMGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=AMGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();